Uttroside B - Rajiv Gandhi Centre for Biotechnology/Q BioMed
Alternative Names: UTTROSIDE-BLatest Information Update: 18 Apr 2023
At a glance
- Originator Oklahoma Medical Research Foundation; Rajiv Gandhi Centre for Biotechnology
- Developer Q BioMed; Rajiv Gandhi Centre for Biotechnology
- Class Antineoplastics; Saponins; Small molecules
- Mechanism of Action Apoptosis stimulants; Mitogen-activated protein kinase modulators; MTOR protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Liver cancer